1. Home
  2. TROX vs CRVS Comparison

TROX vs CRVS Comparison

Compare TROX & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tronox Holdings plc (UK)

TROX

Tronox Holdings plc (UK)

HOLD

Current Price

$5.04

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$14.27

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TROX
CRVS
Founded
2018
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
2012
2016

Fundamental Metrics

Financial Performance
Metric
TROX
CRVS
Price
$5.04
$14.27
Analyst Decision
Hold
Strong Buy
Analyst Count
8
6
Target Price
$6.36
$30.17
AVG Volume (30 Days)
2.6M
718.0K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
2.07%
N/A
EPS Growth
N/A
48.04
EPS
N/A
N/A
Revenue
$2,898,000,000.00
N/A
Revenue This Year
$6.94
N/A
Revenue Next Year
$5.91
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.86
$5.58
52 Week High
$10.59
$26.95

Technical Indicators

Market Signals
Indicator
TROX
CRVS
Relative Strength Index (RSI) 32.27 48.10
Support Level $4.08 $12.76
Resistance Level $5.25 $16.66
Average True Range (ATR) 0.27 0.59
MACD -0.05 -0.08
Stochastic Oscillator 4.07 22.89

Price Performance

Historical Comparison
TROX
CRVS

About TROX Tronox Holdings plc (UK)

Tronox Holdings PLC is a vertically integrated manufacturer of TiO2 pigment. It operates titanium-bearing mineral sand mines and beneficiation and smelting operations in Australia & South Africa to produce feedstock materials that can be processed into TiO2 for pigment, high-purity titanium chemicals, including titanium tetrachloride, and ultrafine TiO2 used in certain specialty applications. TiO2 and titanium feedstock, are used to produce paints and coatings, as well as plastics, paper, and printing ink. It has three pigment production facilities in the United States, the Netherlands, and Western Australia and three mining operations in Western Australia and South Africa. Europe, the Middle East, and Africa regions contribute the majority of revenue.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

Share on Social Networks: